Stratum 1- Regimen CS for Ototoxicity
Study Summary
This trial will test a drug (Sodium Thiosulfate) to see if it can prevent hearing loss from chemotherapy. #medicaltrial
- Ototoxicity
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 2 trial • 21 Patients • NCT02092298Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
What are the criteria for enlistment in this clinical experimentation?
"To partake in this clinical trial, prospective patients must have ototoxicity from a drug-based cause and be between 1 month and 39 years old. Currently, 33 people are being recruited for the study."
Are there any remaining vacancies for those interested in participating within this trial?
"Affirmative. According to clinicaltrials.gov, this experimental research is currently searching for volunteers; it was first published on March 1st 2023 and most recently updated on the 2nd of that same month. The team seeks 33 participants from a single facility."
How extensive is the participant pool of this research experiment?
"Affirmative. The clinicaltrials.gov website exhibits that this trial, which was initially listed on March 1st 2023, is actively recruiting participants. 33 individuals are needed to participate from a single medical site."
Is the age requirement for this trial flexible enough to accept participants aged 70 and over?
"The requirements to become a participant in this research include being between 1 Month and 39 years old. 32 trials are available for minors, while 15 focus on elderly individuals."